<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Moderna’s COVID-19 Vaccine Triggers Immune Response
Image Overlay - Moderna’s COVID-19 Vaccine Triggers Immune Response

Moderna’s COVID-19 Vaccine Triggers Immune Response

July 20, 2020

Moderna’s COVID-19 Vaccine Triggers Immune Response

Moderna has released initial results from its first in human trial of a coronavirus vaccine, which prompted an immune response in all 45 volunteers to receive it. The company has plans to begin a larger phase III clinical trial, which will test 30,000 people, with half receiving a placebo, beginning July 27. This trial is expected to be completed in October. Yourway has the capacity to provide clinical supplies, storage, and transportation for large-scale trials around the world.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat
Come chat with us!
Hello! How can I help you?